Quote | Maxpro Capital Acquisition Corp. Units (NASDAQ:JMACU)
Last: | $11.20 |
---|---|
Change Percent: | 3.3% |
Open: | $10.83 |
Close: | $11.20 |
High: | $11.9 |
Low: | $10.83 |
Volume: | 522 |
Last Trade Date Time: | 03/29/2023 03:00:00 am |
News | Maxpro Capital Acquisition Corp. Units (NASDAQ:JMACU)
Apollomics said on Tuesday that the U.S. Food and Drug Administration (FDA) in August granted orphan drug designation to the company's vebreltinib (APL-101) to treat patients with non-small cell lung cancer (NSCLC) with MET genomic tumor aberrations. Apollomics is going public...
FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) ha...
Message Board Posts | Maxpro Capital Acquisition Corp. Units (NASDAQ:JMACU)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Maxpro Capital Acquisition Corp. Units Company Name:
JMACU Stock Symbol:
NASDAQ Market:
FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) ha...
TAIPEI CITY - ( NewMediaWire ) - October 14, 2022 - Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate amount of $1,035,000 (repr...
Taipei City - ( NewMediaWire ) - October 07, 2022 - Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to...